Relay Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 08/14/2026 | 27.90 M | $522.10 M | 0.00% | 13.76% |
| FMR LLC | 08/13/2026 | 20.11 M | $376.26 M | 444.19% | 9.91% |
| CASDIN CAPITAL, LLC | 08/14/2026 | 16.04 M | $300.02 M | 11.21% | 7.91% |
| BLACKROCK, INC. | 08/07/2026 | 15.29 M | $286.04 M | 17.83% | 7.54% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 14.11 M | $263.93 M | 44.66% | 6.95% |
| COMMODORE CAPITAL LP | 08/14/2026 | 12.00 M | $224.52 M | -29.41% | 5.92% |
| STATE STREET CORP | 08/07/2026 | 10.13 M | $189.47 M | 62.43% | 4.99% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 8.96 M | $167.72 M | 21.35% | 4.42% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 7.71 M | $144.23 M | 300.45% | 3.80% |
| NEXTECH INVEST, LTD. | 08/14/2026 | 6.78 M | $126.79 M | 22.62% | 3.34% |
| BELLEVUE GROUP AG | 08/14/2026 | 6.19 M | $115.74 M | -20.64% | 3.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 4.73 M | $88.45 M | 34.64% | 2.33% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 4.27 M | $79.95 M | 0.00% | 2.11% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 4.10 M | $40.75 M | 2,719.67% | 2.02% |
| MORGAN STANLEY | 08/13/2026 | 3.85 M | $72.05 M | 168.93% | 1.90% |
| SIREN, L.L.C. | 08/13/2026 | 3.65 M | $68.29 M | 100.00% | 1.80% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 3.41 M | $63.78 M | 34.10% | 1.68% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 08/12/2026 | 3.34 M | $62.56 M | 100.00% | 1.65% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 3.30 M | $61.74 M | 131.70% | 1.63% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 3.13 M | $58.53 M | 6.36% | 1.54% |
| SPRUCE STREET CAPITAL LP | 08/13/2026 | 2.98 M | $55.83 M | 0.00% | 1.47% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 2.89 M | $54.12 M | 55.23% | 1.43% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 2.83 M | $52.89 M | 143.66% | 1.39% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 2.70 M | $50.43 M | 39.09% | 1.33% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 2.42 M | $45.20 M | 2.38% | 1.19% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 2.24 M | $41.89 M | 235.02% | 1.10% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 2.08 M | $39.22 M | 10,502.78% | 1.02% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.95 M | $36.55 M | 16.60% | 0.96% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 1.92 M | $35.84 M | 100.00% | 0.94% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 1.86 M | $34.74 M | 3,696.20% | 0.92% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 1.79 M | $33.47 M | 100.00% | 0.88% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 1.74 M | $32.56 M | -32.82% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.50 M | $28.08 M | 34.98% | 0.74% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.50 M | $28.08 M | 100.00% | 0.74% |
| ELMIND CAPITAL, LP | 08/14/2026 | 1.47 M | $27.42 M | 172.89% | 0.72% |
| ALPHABET INC. | 08/07/2026 | 1.41 M | $26.38 M | -9.85% | 0.70% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 1.29 M | $24.16 M | 57.84% | 0.64% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.28 M | $23.94 M | -0.82% | 0.63% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 08/14/2026 | 1.25 M | $23.39 M | 25.00% | 0.62% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 1.25 M | $23.32 M | 1,977.67% | 0.61% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.22 M | $22.90 M | 35.92% | 0.60% |
| UBS GROUP AG | 08/13/2026 | 1.09 M | $20.49 M | 107.54% | 0.54% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 1.08 M | $20.12 M | 100.00% | 0.53% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 1.05 M | $19.65 M | 162.50% | 0.52% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 1.02 M | $19.00 M | 100.00% | 0.50% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 970.00 K | $18.15 M | 546.67% | 0.48% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 961.70 K | $17.99 M | 14.89% | 0.47% |
| WOODLINE PARTNERS LP | 08/14/2026 | 929.69 K | $17.39 M | 36.85% | 0.46% |
| JPMORGAN CHASE & CO | 08/12/2026 | 801.66 K | $15.97 M | 23.80% | 0.40% |
| TIMOTHY G. YOUNGQUIST 2020 IRREVOCABLE TRUST | 08/07/2026 | 801.46 K | $15.00 M | 60.60% | 0.40% |
Relay Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 322 institutional investors and hedge funds held shares of Relay Therapeutics Inc. The most heavily invested institutionals were:
SB INVESTMENT ADVISERS (UK) LTD: 27.9 M
FMR LLC: 20.11 M
Casdin Capital, LLC: 16.04 M
BlackRock, Inc.: 15.29 M
PERCEPTIVE ADVISORS LLC: 14.11 M
COMMODORE CAPITAL LP: 12 M
122.41% of Relay Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 277.35 M shares in the last 24 months. This purchase volume represents approximately $2.81 B in transactions.